Medi-Caps Limited has submitted a regulatory disclosure to BSE Limited regarding the resignation of Mr. Hemant Sethi from his positions as Chief Financial Officer and Key Managerial Personnel (KMP) of the company.
Key Personnel Changes
- Resignation: Mr. Hemant Sethi tendered his resignation via letter dated 03rd June, 2026
- Effective Date: Resignation effective from close of business hours on 06th June, 2026
- Positions Vacated: Chief Financial Officer and Key Managerial Personnel (KMP)
- Additional Roles: All other statutory/designated positions in the company
Reason for Resignation
Mr. Sethi stated the reason for resignation as "to pursue career growth and professional opportunities." He confirmed in his resignation letter that there are no other material reasons for his resignation beyond what was provided.
Regulatory Compliance Details
The disclosure includes Annexure-A prepared in accordance with:
- SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023
- SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December, 2024
Procedural Status
- The resignation letter will be placed before the Board of Directors in the upcoming Board Meeting for consideration and formal acceptance
- The Board has expressed appreciation for Mr. Sethi's valuable services during his tenure
- Mr. Sethi ceased to be the KMP authorized for determining materiality of events and making disclosures to stock exchanges effective from close of business hours on June 6, 2026
Additional Information
- Company website: www.medicaps.com
- Filed by: Abhishek Jain, Company Secretary & Compliance Officer (M. No. A36699)
- Digital signature timestamp: June 8, 2026 at 10:43:31 +05:30
- The information will also be submitted in XBRL format using the exchange-provided Excel template
Financial Impact
No financial impact quantified in the disclosure.